Literature DB >> 6092108

Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM.

D J Nutt, H J Little, S C Taylor, M C Minchin.   

Abstract

A method for measuring seizure thresholds using an intravenous infusion of a convulsant beta-carboline benzodiazepine receptor ligand (DMCM) is reported. Seizure thresholds to DMCM are elevated by the benzodiazepine receptor agonist, flurazepam and antagonist, Ro 15-1788, and the proconvulsant beta-carboline, FG 7142. Various other anticonvulsant also antagonise DMCM seizures. Selectivity for the benzodiazepine/GABA receptor complex is demonstrated since bicuculline and pentylenetetrazol lowered thresholds whereas strychnine and N-methyl DL-aspartate did not.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092108     DOI: 10.1016/0014-2999(84)90500-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study.

Authors:  Y M Hart; H Meinardi; J W Sander; D J Nutt; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

2.  Interactions of the imidazodiazepine Ro 15-4513 with chemical convulsants.

Authors:  R G Lister; D J Nutt
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.